$STIM Income Statement | Understand Stock

$STIM

$2.24 +$0.13 (6.16%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Products and Other
Service
Total Revenues
Cost of revenues
Products and Other
Service
Total Cost of revenues
Gross profit
Operating expenses:
Sales and marketing
General and administrative
Research and development
Total operating expenses
Loss from operations
Other (income) expense:
Interest expense
Loss on extinguishment of debt
Other income, net
Net loss
Less: Net loss attributable to non-controlling interest
Net loss attributable to Neuronetics stockholders'
Net loss per share of common stock outstanding, basic attributable to Neuronetics stockholders'
Net loss per share of common stock outstanding, diluted attributable to Neuronetics stockholders'
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments